David E. Gerber

Emergency Medicine

28155 State Highway 249 Ste 4
Tomball, TX 77375

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 287 publications

DPP9-mediated inflammasome repression protects against checkpoint inhibitor lung toxicity.

DPP9-mediated inflammasome repression protects against checkpoint inhibitor lung toxicity.

Journal: bioRxiv : the preprint server for biology

Published: July 11, 2026

Erratum: Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

Erratum: Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 08, 2026

Patient Perspectives on Electronic Communication of Cancer Diagnoses.

Patient Perspectives on Electronic Communication of Cancer Diagnoses.

Journal: JAMA network open

Published: June 24, 2026

Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 03, 2026

Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 03, 2026

Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial.

Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial.

Journal: JAMA

Published: June 01, 2026

Correction: Metabolic syndrome and immune-related adverse events.

Correction: Metabolic syndrome and immune-related adverse events.

Journal: Cancer immunology, immunotherapy : CII

Published: May 14, 2026

Feasibility of EHR-Based Prescreening for an Adjuvant Breast Cancer Trial in a Safety-Net Health System.

Feasibility of EHR-Based Prescreening for an Adjuvant Breast Cancer Trial in a Safety-Net Health System.

Journal: The oncologist

Published: May 09, 2026

Impact of Voltage on the Production on Spherical Ablations for Integrated Time Nanosecond Pulse Irreversible Electroporation.

Impact of Voltage on the Production on Spherical Ablations for Integrated Time Nanosecond Pulse Irreversible Electroporation.

Journal: Bioelectricity

Published: March 23, 2026

Crizotinib versus observation or placebo for surgically resected early-stage ALK-positive non-small-cell lung cancer (Eastern Cooperative Oncology Group-American College of Radiology Imaging Network E4512): a phase 3 trial.

Crizotinib versus observation or placebo for surgically resected early-stage ALK-positive non-small-cell lung cancer (Eastern Cooperative Oncology Group-American College of Radiology Imaging Network E4512): a phase 3 trial.

Journal: The Lancet. Respiratory medicine

Published: February 06, 2026

Patient-Reported Testing Burden of Low-Dose Chest CT Among Lung Cancer Screening Participants.

Patient-Reported Testing Burden of Low-Dose Chest CT Among Lung Cancer Screening Participants.

Journal: Journal of the American College of Radiology : JACR

Published: February 04, 2026

Patient-Reported Testing Burden of Low-Dose Chest CT Among Lung Cancer Screening Participants.

Patient-Reported Testing Burden of Low-Dose Chest CT Among Lung Cancer Screening Participants.

Journal: Journal of the American College of Radiology : JACR

Published: February 04, 2026

Showing 1-12 of 287

Last Updated: 09/26/2026